Skip Ribbon Commands
Skip to main content
 


Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)


Trial Focus

Trial Focus

Heart & Circulation

Objective

        
The ORBIT-AF registry will be a multicenter, prospective outpatient disease registry to identify "real world" treatment patterns of atrial fibrillation. The registry will describe this patient population with regards to demographics, clinical factors, risk stratification, and geographic regions. In particular, attention will be focused on the utilization, effectiveness, and safety of antithrombotic therapies in the prevention of stroke. The registry is designed to identify reasons and risk factors for non-receipt of anticoagulation (AC) therapy, as well as reasons why AF patients who are prescribed AC therapy do not take them.

Trial Status

In Progress

Contact

Christina Schmitt BS at 303-724-2098 or christina.schmitt@ucdenver.edu

Eligibility and Other Participant Information


Inclusion Criteria
•Adult patients with incident (initial diagnosis) or prevalent (existing diagnosis) AF with electrocardiographic documentation
•anticipated ability to adhere to local regularly scheduled follow-up visits
Exclusion Criteria
•Anticipated life expectancy less than 6 months
•short lasting AF secondary to a reversible condition (e.g. hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery)
•Participation in a randomized trial of anticoagulation for AF at the time of enrollment